InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
56,839.78
(
-2.51%
)
Post# of 222197
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Arthur

Send PM Follow Ignore
Followers 73
Posts 9047
Boards Moderated 0
Alias Born 07/16/2010

Arthur

Re: namtae post# 129760

Friday, 12/01/2017 1:45:45 PM

Friday, December 01, 2017 1:45:45 PM

Post# of 222197
It's highly unethical to subject dying patients to a possibly toxic drug with the lame excuse "their lives weren't worth much anyways".

Besides, doing a Phase One study on sick people cannot possibly give you any useful indication on safe dosages and side effects: if a patient complains of, say, headaches, is it due to their illness, or is it a side effect of the drug being tested ?

The confounding factors are certain to drown the signal.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up